Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays

• Published in: Contraception (Stoneham) 1995, Vol.51 (1), p.45-52
• Main Authors: Fuhrmann, Ulrike, Slater, Emily P., Fritzemeier, Karl-Heinrich
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Cell Line; Contraceptives, Oral - analysis; Contraceptives, Oral - metabolism; Desogestrel - metabolism; Female; Gene Expression; Hormones. Endocrine system; Male; Medical sciences; Norpregnenes - analysis; Norpregnenes - metabolism; oral contraceptive; Pharmacology. Drug treatments; Population; Progesterone - metabolism; progestin; Rabbits; Rats; Rats, Wistar; receptor binding; Receptors, Androgen - analysis; Receptors, Androgen - genetics; Receptors, Androgen - metabolism; Receptors, Cell Surface - analysis; Receptors, Cell Surface - genetics; Receptors, Cell Surface - metabolism; Receptors, Estrogen - analysis; Receptors, Estrogen - genetics; Receptors, Estrogen - metabolism; Receptors, Glucocorticoid - analysis; Receptors, Glucocorticoid - genetics; Receptors, Glucocorticoid - metabolism; Receptors, Mineralocorticoid - analysis; Receptors, Mineralocorticoid - genetics; Receptors, Mineralocorticoid - metabolism; Receptors, Progesterone - analysis; Receptors, Progesterone - genetics; Receptors, Progesterone - metabolism; transactivation; Transcriptional Activation; Transfection
• ISSN: 0010-7824; 1879-0518
• DOI: 10.1016/0010-7824(94)00003-F

Gestodene is a novel progestin used in oral contracepttives with an increased separation of progestogenic versus androgenic activity and a distinct antimineralocorticoid activity. This specific pharmacological profile of gestodene is defined by its pattern of binding affinities to a variety of steroid hormone receptors. In the present study the affinity of gestodene to the progesterone receptor (PR), the androgen receptor (AR), the glucocorticoid receptor (GR), the mineralocorticoid receptor (MR) and the estrogen receptor (ER) was re-evaluated by steroid binding assays and compared to those obtained for 3-keto-desogestrel and progesterone. The two synthetic progestins displayed identical high affinity to rabbit PR and similar marked binding to rat AR and GR, while progesterone showed high affinity to PR but only low binding to AR and GR. Furthermore, 3-keto-desogestrel exhibited almost no binding to MR, whereas gestodene, similar to progesterone, showed marked affinity to this receptor. In addition to receptor binding studies, transactivation assays were carried out to investigated the effects of gestodene on AR-, GR- and MR-mediated induction of transcription. In contrast to progesterone, which showed antiandrogenic activity, gestodene and 3-keto-desogestrel both exhibited androgenic activity. Furthermore, all three progestins exhibited weak GR-mediated antagonistic activity. In contrast to progesterone, which showed almost no glucocorticoid activity, gestodene and 3-keto-desogestrel showed weak glucocorticoid action. In addition, gestodene inhibited the aldosterone-induced reporter gene transcription, similar to progesterone, whereas unlike progesterone, gestodene did not induce reporter gene transcription. 3-Keto-desogestrel showed neither antimineralocorticoid nor mineralocorticoid action.